Identification of marker genes associated with oxidative stress in hypertrophic cardiomyopathy using bioinformatics

Jian Zhuo1, Ding Ding2, Mengkang Fan3

  • 1Department of Cardiology, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, China. 1931320060@stmail.ntu.edu.cn.

Scientific Reports
|August 7, 2025
PubMed

Insights

This study identifies seven key oxidative stress genes contributing to hypertrophic cardiomyopathy (HCM). These genes are linked to apoptosis and immune responses, offering new insights into HCM development.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Biology
  • Bioinformatics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a prevalent inherited heart condition.
  • The precise role of oxidative stress in HCM pathogenesis remains incompletely understood.

Purpose of the Study:

  • To identify and characterize oxidative stress-related genes associated with HCM.
  • To elucidate the functional significance of these genes in HCM development using bioinformatic approaches.

Main Methods:

  • Bioinformatic analysis of public gene expression datasets (GSE36961, GSE141910).
  • Identification of oxidative stress-related differentially expressed genes (OS-DEGs) using LASSO and SVM-RFE algorithms.
  • Functional enrichment analyses (GO, pathway, GSEA) and immune cell infiltration analysis (CIBERSORT).
  • In vitro validation in neonatal rat cardiomyocytes.

Main Results:

  • 33 OS-DEGs linked to HCM were identified, primarily associated with apoptosis and immune response.
  • Seven marker genes (JAK2, EDNRA, KCNA5, DNAJC15, CA3, PRKCD, KLF2) were pinpointed.
  • Functional analysis indicated these markers regulate oxidative stress, immune responses, and cytokine interactions in HCM.
  • In vitro studies confirmed elevated oxidative stress and apoptosis in HCM models.

Conclusions:

  • This study identified seven novel oxidative stress-related genes implicated in HCM pathogenesis.
  • Oxidative stress likely contributes to HCM through apoptosis and modulation of immune responses.
  • PRKCD and EDNRA may influence the immune microenvironment in HCM patients.